Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-16-141657

Options or other derivatives

  • Chief Business Officer acquired 45,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ravindran Sanuj K. Chief Business Officer 2016-09-13 Grant or award · Employee Stock Option (right to buy) +45,500 45,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…